{"version":"1.0","provider_name":"Paksoy Attorneys at Law","provider_url":"https:\/\/paksoy.av.tr\/en\/","author_name":"Paksoy","author_url":"https:\/\/paksoy.av.tr\/en\/team\/pseditor\/","title":"Recent Developments in Healthcare Legislation - Q2 2025 | Paksoy Attorneys at Law","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"eqUeBMtygv\"><a href=\"https:\/\/paksoy.av.tr\/en\/2025\/07\/recent-developments-in-healthcare-legislation-q2-2025\/\">Recent Developments in Healthcare Legislation &#8211; Q2 2025<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/paksoy.av.tr\/en\/2025\/07\/recent-developments-in-healthcare-legislation-q2-2025\/embed\/#?secret=eqUeBMtygv\" width=\"600\" height=\"338\" title=\"&#8220;Recent Developments in Healthcare Legislation &#8211; Q2 2025&#8221; &#8212; Paksoy Attorneys at Law\" data-secret=\"eqUeBMtygv\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/paksoy.av.tr\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/paksoy.av.tr\/wp-content\/uploads\/2025\/07\/Newsletter-Pharma-Spring-2025.jpg","thumbnail_width":2000,"thumbnail_height":1125,"description":"Amendment to the Regulation on the Clinical Trials of Medicinal Products for Human Use. On 5 June 2025, the Regulation on Clinical Trials of Medicinal Products for Human Use underwent certain amendments. Prior to the assignment of the research team, information regarding the principal investigators shall be submitted to both the ethics committee and the Turkish Medicines and Medical Devices Agency (\u201cAgency\u201d), information regarding the auxiliary clinical research staff will be submitted to the ethics committee first and to the Agency if and when requested by the Agency."}